A moderate low-carbohydrate diet for adults with type 1 diabetes has advantages over traditional diet.
J&J’s Janssen nabs new indication, full approval for cancer drug Rybrevant
Johnson & Johnson’s Janssen on Friday earned an FDA approval for its cancer drug Rybrevant (amivantamab-vmjw) for the first-line treatment of locally advanced or metastatic